{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:03:23Z","timestamp":1782504203511,"version":"3.54.5"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Chongqing Science and Technology Development Foundation","award":["CSTB2024NSCQ-KJFZMSX0050"],"award-info":[{"award-number":["CSTB2024NSCQ-KJFZMSX0050"]}]},{"name":"Chongqing Science and Technology Development Foundation","award":["CSTB2024NSCQ-KJFZMSX0046"],"award-info":[{"award-number":["CSTB2024NSCQ-KJFZMSX0046"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10147-026-02987-3","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:50:49Z","timestamp":1778853049000},"page":"1161-1174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["From tumor microenvironment orchestrators to actionable targets: a systematic review of TAM-targeted therapies in triple-negative breast cancer"],"prefix":"10.1007","volume":"31","author":[{"given":"Yuxin","family":"Pei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8150-2624","authenticated-orcid":false,"given":"Wanyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"issue":"1","key":"2987_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03312-y","volume":"44","author":"Q He","year":"2025","unstructured":"He Q, Hu J, Ngo FY et al (2025) Targeting TUBB2B inhibits triple-negative breast cancer growth and brain-metastatic colonization. J Exp Clin Cancer Res 44(1):55","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2987_CR2","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2023.2183830","volume":"30","author":"L Tang","year":"2023","unstructured":"Tang L, Huang K, Jiang W et al (2023) Exploration of the inhibition action of TPGS on tumor cells and its combined use with chemotherapy drugs. Drug Deliv 30(1):2183830","journal-title":"Drug Deliv"},{"key":"2987_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2024.103835","volume":"79","author":"M Fu","year":"2025","unstructured":"Fu M, Peng Z, Wu M et al (2025) Current and future burden of breast cancer in Asia: a GLOBOCAN data analysis for 2022 and 2050. Breast Edinb Scotl 79:103835","journal-title":"Breast Edinb Scotl"},{"issue":"6797","key":"2987_CR4","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, S\u00f8rlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406(6797):747\u2013752","journal-title":"Nature"},{"issue":"1","key":"2987_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41392-025-02137-7","volume":"10","author":"G Shen","year":"2025","unstructured":"Shen G, Liu Z, Wang M et al (2025) Neoadjuvant apatinib addition to sintilimab and carboplatin-taxane based chemotherapy in patients with early triple-negative breast cancer: the phase 2 NeoSAC trial. Signal Transduct Target Ther 10(1):41","journal-title":"Signal Transduct Target Ther"},{"key":"2987_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.177202","volume":"988","author":"L Xu","year":"2025","unstructured":"Xu L, Xu P, Wang J et al (2025) Advancements in clinical research and emerging therapies for triple-negative breast cancer treatment. Eur J Pharmacol 988:177202","journal-title":"Eur J Pharmacol"},{"key":"2987_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00714-6","volume":"12","author":"Z Guo","year":"2024","unstructured":"Guo Z, Zhu Z, Lin X et al (2024) Tumor microenvironment and immunotherapy for triple-negative breast cancer. Biomark Res 12:166","journal-title":"Biomark Res"},{"issue":"1","key":"2987_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02134-w","volume":"10","author":"N Robinson","year":"2025","unstructured":"Robinson N, Polara R, Thomas D (2025) IRE1\u03b1: a gatekeeper of chemotherapy-induced immunogenicity in triple-negative breast cancer. Signal Transduct Target Ther 10(1):52","journal-title":"Signal Transduct Target Ther"},{"key":"2987_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00766","volume":"8","author":"L Nagl","year":"2020","unstructured":"Nagl L, Horvath L, Pircher A et al (2020) Tumor endothelial cells (TECs) as potential immune directors of the tumor microenvironment - new findings and future perspectives. Front Cell Dev Biol 8:766","journal-title":"Front Cell Dev Biol"},{"key":"2987_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113930","volume":"147","author":"C Wang","year":"2025","unstructured":"Wang C, Liu Y, Zhang R et al (2025) Targeting the tumor immune microenvironment: GPCRs as key regulators in triple-negative breast cancer. Int Immunopharmacol 147:113930","journal-title":"Int Immunopharmacol"},{"key":"2987_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1528248","volume":"15","author":"S-L Chen","year":"2025","unstructured":"Chen S-L, Fei Y-R, Cai X-X et al (2025) Exploring the role of metabolic pathways in TNBC immunotherapy: insights from single-cell and spatial transcriptomics. Front Endocrinol 15:1528248","journal-title":"Front Endocrinol"},{"issue":"Pt 2","key":"2987_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113387","volume":"143","author":"Y Qi","year":"2024","unstructured":"Qi Y, Li R, Han M (2024) Tumor-associated macrophages induce epithelial-mesenchymal transition and promote lung metastasis in breast cancer by activating the IL-6\/STAT3\/TGM2 axis. Int Immunopharmacol 143(Pt 2):113387","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"2987_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54145-w","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, Venet D, Lifrange F et al (2024) Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications. Nat Commun 15(1):10232","journal-title":"Nat Commun"},{"issue":"1","key":"2987_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40487-022-00214-3","volume":"11","author":"E Allison","year":"2023","unstructured":"Allison E, Edirimanne S, Matthews J et al (2023) Breast cancer survival outcomes and tumor-associated macrophage markers: a systematic review and meta-analysis. Oncol Ther 11(1):27\u201348","journal-title":"Oncol Ther"},{"key":"2987_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.123028","volume":"316","author":"X Shi","year":"2025","unstructured":"Shi X, Askari Rizvi SF, Yang Y et al (2025) Emerging nanomedicines for macrophage-mediated cancer therapy. Biomaterials 316:123028","journal-title":"Biomaterials"},{"issue":"7","key":"2987_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073901","volume":"23","author":"C O\u2019Mahony","year":"2022","unstructured":"O\u2019Mahony C, Amamou A, Ghosh S (2022) Diet\u2013microbiota interplay: an emerging player in macrophage plasticity and intestinal health. Int J Mol Sci 23(7):3901","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2987_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abl9171","volume":"8","author":"X Cao","year":"2022","unstructured":"Cao X, Chen J, Li B et al (2022) Promoting antibody-dependent cellular phagocytosis for effective macrophage-based cancer immunotherapy. Sci Adv 8(11):eabl9171","journal-title":"Sci Adv"},{"issue":"6","key":"2987_CR18","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a021857","volume":"6","author":"ER Stanley","year":"2014","unstructured":"Stanley ER, Chitu V (2014) Csf-1 receptor signaling in myeloid cells. Cold Spring Harb Perspect Biol 6(6):a021857","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2987_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01165-x","volume":"19","author":"H Yang","year":"2020","unstructured":"Yang H, Zhang Q, Xu M et al (2020) CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis. Mol Cancer 19:41","journal-title":"Mol Cancer"},{"key":"2987_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-021-00252-z","volume":"10","author":"S Zhu","year":"2021","unstructured":"Zhu S, Yi M, Wu Y et al (2021) Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies. Exp Hematol Oncol 10:60","journal-title":"Exp Hematol Oncol"},{"key":"2987_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02233-w","volume":"24","author":"L Kuang","year":"2025","unstructured":"Kuang L, Wu L, Li Y (2025) Extracellular vesicles in tumor immunity: mechanisms and novel insights. Mol Cancer 24:45","journal-title":"Mol Cancer"},{"issue":"7868","key":"2987_CR22","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-021-03651-8","volume":"595","author":"M Casanova-Acebes","year":"2021","unstructured":"Casanova-Acebes M, Dalla E, Leader AM et al (2021) Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells. Nature 595(7868):578\u2013584","journal-title":"Nature"},{"issue":"11","key":"2987_CR23","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1016\/j.apsb.2020.04.004","volume":"10","author":"Q Yang","year":"2020","unstructured":"Yang Q, Guo N, Zhou Y et al (2020) The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy. Acta Pharm Sin B 10(11):2156\u20132170","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"2987_CR24","doi-asserted-by":"publisher","first-page":"2060907","DOI":"10.1080\/2162402X.2022.2060907","volume":"11","author":"MTSS SuKumataEndo","year":"2022","unstructured":"SuKumataEndo MTSS et al (2022) LILRB4 promotes tumor metastasis by regulating MDSCs and inhibiting miR-1 family miRNAs. Oncoimmunology. 11(1):2060907","journal-title":"Oncoimmunology."},{"issue":"2","key":"2987_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/intimm\/dxs110","volume":"25","author":"E Riboldi","year":"2013","unstructured":"Riboldi E, Porta C, Morlacchi S et al (2013) Hypoxia-mediated regulation of macrophage functions in pathophysiology. Int Immunol 25(2):67\u201375","journal-title":"Int Immunol"},{"issue":"1","key":"2987_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41423-019-0306-1","volume":"17","author":"K Nakamura","year":"2020","unstructured":"Nakamura K, Smyth MJ (2020) Myeloid immunosuppression and immune checkpoints in the tumor microenvironment. Cell Mol Immunol 17(1):1\u201312","journal-title":"Cell Mol Immunol"},{"issue":"7","key":"2987_CR27","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1073\/pnas.1113744109","volume":"109","author":"V Cortez-Retamozo","year":"2012","unstructured":"Cortez-Retamozo V, Etzrodt M, Newton A et al (2012) Origins of tumor-associated macrophages and neutrophils. Proc Natl Acad Sci U S A 109(7):2491\u20132496","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2987_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12943-025-02249-2","volume":"24","author":"SY Park","year":"2025","unstructured":"Park SY, Pylaeva E, Bhuria V et al (2025) Harnessing myeloid cells in cancer. Mol Cancer 24(1):69","journal-title":"Mol Cancer"},{"issue":"11","key":"2987_CR29","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nri3088","volume":"11","author":"T Lawrence","year":"2011","unstructured":"Lawrence T, Natoli G (2011) Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 11(11):750\u2013761","journal-title":"Nat Rev Immunol"},{"key":"2987_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00111","volume":"11","author":"TL Fernandes","year":"2020","unstructured":"Fernandes TL, Gomoll AH, Lattermann C et al (2020) Macrophage: a potential target on cartilage regeneration. Front Immunol 11:111","journal-title":"Front Immunol"},{"issue":"3","key":"2987_CR31","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/cdd.2012.146","volume":"20","author":"CP Chang","year":"2013","unstructured":"Chang CP, Su YC, Hu CW et al (2013) TLR2-dependent selective autophagy regulates NF-\u03baB lysosomal degradation in hepatoma-derived M2 macrophage differentiation. Cell Death Differ 20(3):515\u2013523","journal-title":"Cell Death Differ"},{"issue":"3","key":"2987_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119751","volume":"10","author":"E Derlindati","year":"2015","unstructured":"Derlindati E, Dei Cas A, Montanini B et al (2015) Transcriptomic analysis of human polarized macrophages: more than one role of alternative activation? PLoS One 10(3):e0119751","journal-title":"PLoS One"},{"issue":"11","key":"2987_CR33","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nri3073","volume":"11","author":"PJ Murray","year":"2011","unstructured":"Murray PJ, Wynn TA (2011) Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11(11):723\u2013737","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2987_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0860-x","volume":"37","author":"J Steenbrugge","year":"2018","unstructured":"Steenbrugge J, Breyne K, Demeyere K et al (2018) Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer. J Exp Clin Cancer Res 37(1):191","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"2987_CR35","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1172\/JCI31422","volume":"117","author":"A Sica","year":"2007","unstructured":"Sica A, Bronte V (2007) Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 117(5):1155\u20131166","journal-title":"J Clin Invest"},{"issue":"7","key":"2987_CR36","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/cr.2013.75","volume":"23","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Choksi S, Chen K et al (2013) ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages. Cell Res 23(7):898\u2013914","journal-title":"Cell Res"},{"key":"2987_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03393-9","volume":"20","author":"J He","year":"2022","unstructured":"He J, Chen Z, Xue Q et al (2022) Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature. J Transl Med 20:186","journal-title":"J Transl Med"},{"issue":"2","key":"2987_CR38","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.cellsig.2013.11.004","volume":"26","author":"D Zhou","year":"2014","unstructured":"Zhou D, Huang C, Lin Z et al (2014) Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell Signal 26(2):192\u2013197","journal-title":"Cell Signal"},{"issue":"6\u20138","key":"2987_CR39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.imbio.2006.06.002","volume":"211","author":"JA Van Ginderachter","year":"2006","unstructured":"Van Ginderachter JA, Movahedi K, Hassanzadeh Ghassabeh G et al (2006) Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology 211(6\u20138):487\u2013501","journal-title":"Immunobiology"},{"key":"2987_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.708186","volume":"12","author":"EA Ross","year":"2021","unstructured":"Ross EA, Devitt A, Johnson JR (2021) Macrophages: the good, the bad, and the gluttony. Front Immunol 12:708186","journal-title":"Front Immunol"},{"issue":"24","key":"2987_CR41","doi-asserted-by":"publisher","first-page":"11743","DOI":"10.1158\/0008-5472.CAN-05-0045","volume":"65","author":"P Sinha","year":"2005","unstructured":"Sinha P, Clements VK, Ostrand-Rosenberg S (2005) Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis. Cancer Res 65(24):11743\u201311751","journal-title":"Cancer Res"},{"issue":"1","key":"2987_CR42","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/imr.12218","volume":"262","author":"S Colin","year":"2014","unstructured":"Colin S, Chinetti-Gbaguidi G, Staels B (2014) Macrophage phenotypes in atherosclerosis. Immunol Rev 262(1):153\u2013166","journal-title":"Immunol Rev"},{"issue":"9","key":"2987_CR43","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam A, Mohammadian S, Vazini H et al (2018) Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol 233(9):6425\u20136440","journal-title":"J Cell Physiol"},{"issue":"1","key":"2987_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-022-00384-y","volume":"27","author":"AT Gharavi","year":"2022","unstructured":"Gharavi AT, Hanjani NA, Movahed E et al (2022) The role of macrophage subtypes and exosomes in immunomodulation. Cell Mol Biol Lett 27(1):83","journal-title":"Cell Mol Biol Lett"},{"key":"2987_CR45","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","volume":"15","author":"M Locati","year":"2020","unstructured":"Locati M, Curtale G, Mantovani A (2020) Diversity, mechanisms and significance of macrophage plasticity. Annu Rev Pathol 15:123\u2013147","journal-title":"Annu Rev Pathol"},{"issue":"10","key":"2987_CR46","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/ni.1937","volume":"11","author":"SK Biswas","year":"2010","unstructured":"Biswas SK, Mantovani A (2010) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 11(10):889\u2013896","journal-title":"Nat Immunol"},{"issue":"1","key":"2987_CR47","first-page":"221","volume":"167","author":"U Grohmann","year":"1950","unstructured":"Grohmann U, Belladonna ML, Vacca C et al (1950) 2001 Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma. J Immunol Baltim Md 167(1):221\u2013227","journal-title":"J Immunol Baltim Md"},{"issue":"7446","key":"2987_CR48","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature12034","volume":"496","author":"TA Wynn","year":"2013","unstructured":"Wynn TA, Chawla A, Pollard JW (2013) Macrophage biology in development, homeostasis and disease. Nature 496(7446):445\u2013455","journal-title":"Nature"},{"issue":"8","key":"2987_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084104","volume":"23","author":"M Holthaus","year":"2022","unstructured":"Holthaus M, Santhakumar N, Wahlers T et al (2022) The secretome of preconditioned mesenchymal stem cells drives polarization and reprogramming of M2a macrophages toward an IL-10-producing phenotype. Int J Mol Sci 23(8):4104","journal-title":"Int J Mol Sci"},{"issue":"9","key":"2987_CR50","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1016\/j.neurobiolaging.2015.05.016","volume":"36","author":"DM Wilcock","year":"2015","unstructured":"Wilcock DM, Hurban J, Helman AM et al (2015) Down syndrome individuals with Alzheimer\u2019s disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer\u2019s disease. Neurobiol Aging 36(9):2468\u20132474","journal-title":"Neurobiol Aging"},{"issue":"8","key":"2987_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087493","volume":"24","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Sioud M (2023) Tumor-associated macrophage subsets: shaping polarization and targeting. Int J Mol Sci 24(8):7493","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2987_CR52","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/JLB.6A1120-744R","volume":"111","author":"CB Anders","year":"2022","unstructured":"Anders CB, Lawton TMW, Smith HL et al (2022) Use of integrated metabolomics, transcriptomics, and signal protein profile to characterize the effector function and associated metabotype of polarized macrophage phenotypes. J Leukoc Biol 111(3):667\u2013693","journal-title":"J Leukoc Biol"},{"issue":"5","key":"2987_CR53","first-page":"8027","volume":"15","author":"WJ Yang","year":"2018","unstructured":"Yang WJ, Hao YX, Yang X et al (2018) Overexpression of Tie2 is associated with poor prognosis in patients with gastric cancer. Oncol Lett 15(5):8027\u20138033","journal-title":"Oncol Lett"},{"key":"2987_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66580-y","volume":"10","author":"X Yin","year":"2020","unstructured":"Yin X, Zhang B, Chen L et al (2020) Essential contribution of macrophage Tie2 signalling in a murine model of laser-induced choroidal neovascularization. Sci Rep 10:9613","journal-title":"Sci Rep"},{"issue":"2","key":"2987_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112715","volume":"405","author":"X Zhou","year":"2021","unstructured":"Zhou X, Xu Y, Ren S et al (2021) Single-cell RNA-seq revealed diverse cell types in the mouse placenta at mid-gestation. Exp Cell Res 405(2):112715","journal-title":"Exp Cell Res"},{"issue":"1","key":"2987_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-023-02074-6","volume":"10","author":"KH Prazanowska","year":"2023","unstructured":"Prazanowska KH, Lim SB (2023) An integrated single-cell transcriptomic dataset for non-small cell lung cancer. Sci Data 10(1):167","journal-title":"Sci Data"},{"issue":"19","key":"2987_CR57","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1126\/sciadv.ade3559","volume":"9","author":"R Sun","year":"2023","unstructured":"Sun R, Han R, McCornack C et al (2023) TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma. Sci Adv 9(19):3559","journal-title":"Sci Adv"},{"issue":"11","key":"2987_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14112711","volume":"14","author":"C Ucaryilmaz Metin","year":"2022","unstructured":"Ucaryilmaz Metin C, Ozcan G (2022) The HIF-1\u03b1 as a potent inducer of the hallmarks in gastric cancer. Cancers 14(11):2711","journal-title":"Cancers"},{"key":"2987_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100904","volume":"66","author":"J Li","year":"2023","unstructured":"Li J, Zhu L, Kwok HF (2023) Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment. Drug Resist Updat 66:100904","journal-title":"Drug Resist Updat"},{"issue":"1","key":"2987_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-02659-4","volume":"30","author":"JJ Hu","year":"2025","unstructured":"Hu JJ, Zhang QY, Yang ZC (2025) The correlation between obesity and the occurrence and development of breast cancer. Eur J Med Res 30(1):419","journal-title":"Eur J Med Res"},{"issue":"2","key":"2987_CR61","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.canlet.2008.03.028","volume":"267","author":"A Sica","year":"2008","unstructured":"Sica A, Allavena P, Mantovani A (2008) Cancer related inflammation: the macrophage connection. Cancer Lett 267(2):204\u2013215","journal-title":"Cancer Lett"},{"issue":"33","key":"2987_CR62","doi-asserted-by":"publisher","first-page":"34758","DOI":"10.18632\/oncotarget.5325","volume":"6","author":"L Lin","year":"2015","unstructured":"Lin L, Chen YS, Yao YD et al (2015) CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer. Oncotarget 6(33):34758\u201334773","journal-title":"Oncotarget"},{"key":"2987_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.05.027","volume":"175","author":"LJW Tang","year":"2021","unstructured":"Tang LJW, Zaseela A, Toh CCM et al (2021) Engineering stromal heterogeneity in cancer. Adv Drug Deliv Rev 175:113817","journal-title":"Adv Drug Deliv Rev"},{"key":"2987_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02618-z","volume":"18","author":"I Hwang","year":"2020","unstructured":"Hwang I, Kim JW, Ylaya K et al (2020) Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients. J Transl Med 18:443","journal-title":"J Transl Med"},{"key":"2987_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54920-9","volume":"15","author":"CJ Lee","year":"2024","unstructured":"Lee CJ, Jang TY, Jeon SE et al (2024) The dysadherin\/MMP9 axis modifies the extracellular matrix to accelerate colorectal cancer progression. Nat Commun 15:10422","journal-title":"Nat Commun"},{"key":"2987_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01147-6","volume":"14","author":"JW Lee","year":"2021","unstructured":"Lee JW, Hur J, Kwon YW et al (2021) KAI1(CD82) is a key molecule to control angiogenesis and switch angiogenic milieu to quiescent state. J Hematol Oncol 14:148","journal-title":"J Hematol Oncol"},{"issue":"11","key":"2987_CR67","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1073\/pnas.1700600114","volume":"114","author":"C Carmona-Fontaine","year":"2017","unstructured":"Carmona-Fontaine C, Deforet M, Akkari L et al (2017) Metabolic origins of spatial organization in the tumor microenvironment. Proc Natl Acad Sci U S A 114(11):2934\u20132939","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2987_CR68","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ccell.2024.03.013","volume":"42","author":"W Wang","year":"2024","unstructured":"Wang W, Li T, Cheng Y et al (2024) Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization. Cancer Cell 42(5):815-832.e12","journal-title":"Cancer Cell"},{"issue":"4","key":"2987_CR69","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nri2528","volume":"9","author":"JW Pollard","year":"2009","unstructured":"Pollard JW (2009) Trophic macrophages in development and disease. Nat Rev Immunol 9(4):259\u2013270","journal-title":"Nat Rev Immunol"},{"issue":"19","key":"2987_CR70","doi-asserted-by":"publisher","first-page":"7022","DOI":"10.1158\/0008-5472.CAN-04-1449","volume":"64","author":"J Wyckoff","year":"2004","unstructured":"Wyckoff J, Wang W, Lin EY et al (2004) A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64(19):7022\u20137029","journal-title":"Cancer Res"},{"key":"2987_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1404687","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Ding X, Zhang X et al (2024) Unveiling the contribution of tumor-associated macrophages in driving epithelial-mesenchymal transition: a review of mechanisms and therapeutic strategies. Front Pharmacol 15:1404687","journal-title":"Front Pharmacol"},{"issue":"9","key":"2987_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0876-3","volume":"9","author":"N Wang","year":"2018","unstructured":"Wang N, Liu W, Zheng Y et al (2018) CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-\u03baB\/SOX4 signaling. Cell Death Dis 9(9):880","journal-title":"Cell Death Dis"},{"issue":"12","key":"2987_CR73","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1002\/jcp.25797","volume":"232","author":"T Chen","year":"2017","unstructured":"Chen T, You Y, Jiang H et al (2017) Epithelial-mesenchymal transition (EMT): a biological process in the development, stem cell differentiation and tumorigenesis. J Cell Physiol 232(12):3261\u20133272","journal-title":"J Cell Physiol"},{"issue":"4","key":"2987_CR74","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR (2018) Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol 15(4):234\u2013248","journal-title":"Nat Rev Clin Oncol"},{"key":"2987_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00888-2","volume":"20","author":"X Chen","year":"2022","unstructured":"Chen X, Yang M, Yin J et al (2022) Tumor-associated macrophages promote epithelial\u2013mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2\/AKT\/\u03b2-catenin signaling. Cell Commun Signal 20:92","journal-title":"Cell Commun Signal"},{"issue":"2","key":"2987_CR76","doi-asserted-by":"publisher","first-page":"446","DOI":"10.7150\/ijbs.86085","volume":"20","author":"L Wang","year":"2024","unstructured":"Wang L, Zhang L, Zhao L et al (2024) VEGFA\/NRP-1\/GAPVD1 axis promotes progression and cancer stemness of triple-negative breast cancer by enhancing tumor cell-macrophage crosstalk. Int J Biol Sci 20(2):446\u2013463","journal-title":"Int J Biol Sci"},{"issue":"4","key":"2987_CR77","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.tcb.2010.12.002","volume":"21","author":"SD Mason","year":"2011","unstructured":"Mason SD, Joyce JA (2011) Proteolytic networks in cancer. Trends Cell Biol 21(4):228\u2013237","journal-title":"Trends Cell Biol"},{"issue":"2","key":"2987_CR78","first-page":"1197","volume":"175","author":"T Hagemann","year":"1950","unstructured":"Hagemann T, Wilson J, Kulbe H et al (1950) 2005 Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol Baltim Md 175(2):1197\u20131205","journal-title":"J Immunol Baltim Md"},{"key":"2987_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1494462","volume":"15","author":"M Friedman-DeLuca","year":"2024","unstructured":"Friedman-DeLuca M, Karagiannis GS, Condeelis JS et al (2024) Macrophages in tumor cell migration and metastasis. Front Immunol 15:1494462","journal-title":"Front Immunol"},{"issue":"5","key":"2987_CR80","doi-asserted-by":"publisher","first-page":"6654","DOI":"10.1096\/fj.201903082R","volume":"34","author":"B Acosta-Iborra","year":"2020","unstructured":"Acosta-Iborra B, Tiana M, Maeso-Alonso L et al (2020) Hypoxia compensates cell cycle arrest with progenitor differentiation during angiogenesis. FASEB J 34(5):6654\u20136674","journal-title":"FASEB J"},{"issue":"1","key":"2987_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01460-1","volume":"8","author":"ZL Liu","year":"2023","unstructured":"Liu ZL, Chen HH, Zheng LL et al (2023) Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Ther 8(1):198","journal-title":"Signal Transduct Target Ther"},{"key":"2987_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.702785","volume":"12","author":"M Lavy","year":"2021","unstructured":"Lavy M, Gauttier V, Poirier N (2021) Specialized pro-resolving mediators mitigate cancer-related inflammation: role of tumor-associated macrophages and therapeutic opportunities. Front Immunol 12:702785","journal-title":"Front Immunol"},{"issue":"1","key":"2987_CR83","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00262-020-02669-7","volume":"70","author":"X Bao","year":"2020","unstructured":"Bao X, Shi R, Zhao T et al (2020) Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC. Cancer Immunol Immunother 70(1):189\u2013202","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"2987_CR84","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-024-01417-w","volume":"24","author":"A Salmaninejad","year":"2024","unstructured":"Salmaninejad A, Layeghi SM, Falakian Z et al (2024) An update to experimental and clinical aspects of tumor-associated macrophages in cancer development: hopes and pitfalls. Clin Exp Med 24(1):156","journal-title":"Clin Exp Med"},{"issue":"1","key":"2987_CR85","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2023.2175517","volume":"12","author":"Z Chen","year":"2023","unstructured":"Chen Z, Tong L, Neo SY et al (2023) CD25bright NK cells display superior function and metabolic activity under regulatory T cell-mediated suppression. Oncoimmunology 12(1):2175517","journal-title":"Oncoimmunology"},{"issue":"4","key":"2987_CR86","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/leu.2015.327","volume":"30","author":"RH Rouce","year":"2016","unstructured":"Rouce RH, Shaim H, Sekine T et al (2016) The TGF-\u03b2\/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B acute lymphoblastic leukemia. Leukemia 30(4):800\u2013811","journal-title":"Leukemia"},{"issue":"1","key":"2987_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00714-6","volume":"12","author":"Z Guo","year":"2024","unstructured":"Guo Z, Zhu Z, Lin X et al (2024) Tumor microenvironment and immunotherapy for triple-negative breast cancer. Biomark Res 12(1):166","journal-title":"Biomark Res"},{"key":"2987_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100907","volume":"66","author":"K Pang","year":"2023","unstructured":"Pang K, Shi ZD, Wei LY et al (2023) Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1\/PD-L1 blockade. Drug Resist Updat 66:100907","journal-title":"Drug Resist Updat"},{"issue":"7655","key":"2987_CR89","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature22396","volume":"545","author":"SR Gordon","year":"2017","unstructured":"Gordon SR, Maute RL, Dulken BW et al (2017) PD-1 expression by tumor-associated macrophages inhibits phagocytosis and tumor immunity. Nature 545(7655):495\u2013499","journal-title":"Nature"},{"issue":"16","key":"2987_CR90","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1016\/j.jmb.2016.03.021","volume":"428","author":"GA Rabinovich","year":"2016","unstructured":"Rabinovich GA, Conejo-Garc\u00eda JR (2016) Shaping the immune landscape in cancer by galectin-driven regulatory pathways. J Mol Biol 428(16):3266\u20133281","journal-title":"J Mol Biol"},{"issue":"20","key":"2987_CR91","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.1182\/blood-2010-11-318675","volume":"117","author":"CL Lucas","year":"2011","unstructured":"Lucas CL, Workman CJ, Beyaz S et al (2011) LAG-3, TGF-\u03b2, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L. Blood 117(20):5532\u20135540","journal-title":"Blood"},{"issue":"8","key":"2987_CR92","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1084\/jem.20082492","volume":"206","author":"KS Peggs","year":"2009","unstructured":"Peggs KS, Quezada SA, Chambers CA et al (2009) Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies. J Exp Med 206(8):1717\u20131725","journal-title":"J Exp Med"},{"key":"2987_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03302-0","volume":"44","author":"J Yang","year":"2025","unstructured":"Yang J, Tang S, Saba NF et al (2025) Tumor secretome shapes the immune landscape during cancer progression. J Exp Clin Cancer Res 44:47","journal-title":"J Exp Clin Cancer Res"},{"issue":"7806","key":"2987_CR94","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41586-020-2229-5","volume":"581","author":"K Yamamoto","year":"2020","unstructured":"Yamamoto K, Venida A, Yano J et al (2020) Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature 581(7806):100\u2013105","journal-title":"Nature"},{"issue":"2","key":"2987_CR95","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1136\/gutjnl-2021-325564","volume":"72","author":"M Alonso-Nocelo","year":"2023","unstructured":"Alonso-Nocelo M, Ruiz-Ca\u00f1as L, Sancho P et al (2023) Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma. Gut 72(2):345\u2013359","journal-title":"Gut"},{"issue":"5","key":"2987_CR96","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.4049\/jimmunol.1900789","volume":"205","author":"AMH Larsen","year":"2020","unstructured":"Larsen AMH, Kuczek DE, Kalvisa A et al (2020) Collagen density modulates the immunosuppressive functions of macrophages. J Immunol 205(5):1461\u20131472","journal-title":"J Immunol"},{"issue":"24","key":"2987_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15245795","volume":"15","author":"H Zhou","year":"2023","unstructured":"Zhou H, Yao J, Zhong Z et al (2023) Lactate-induced CCL8 in tumor-associated macrophages accelerates the progression of colorectal cancer through the CCL8\/CCR5\/mTORC1 axis. Cancers 15(24):5795","journal-title":"Cancers"},{"issue":"12","key":"2987_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/biom14121646","volume":"14","author":"ZN Hao","year":"2024","unstructured":"Hao ZN, Tan XP, Zhang Q et al (2024) Lactate and lactylation: dual regulators of T-cell-mediated tumor immunity and immunotherapy. Biomolecules 14(12):1646","journal-title":"Biomolecules"},{"key":"2987_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03025-8","volume":"43","author":"C Yan","year":"2024","unstructured":"Yan C, Yang Z, Chen P et al (2024) GPR65 sensing tumor-derived lactate induces HMGB1 release from TAM via the cAMP\/PKA\/CREB pathway to promote glioma progression. J Exp Clin Cancer Res 43:105","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"2987_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijo.2021.5239","volume":"59","author":"S Chen","year":"2021","unstructured":"Chen S, Morine Y, Tokuda K et al (2021) Cancer-associated fibroblast-induced M2-polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor-1 pathway. Int J Oncol 59(2):1\u201314","journal-title":"Int J Oncol"},{"issue":"18","key":"2987_CR101","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1158\/0008-5472.CAN-22-1427","volume":"82","author":"E Timperi","year":"2022","unstructured":"Timperi E, Gueguen P, Molgora M et al (2022) Lipid-associated macrophages are induced by cancer-associated fibroblasts and mediate immune suppression in breast cancer. Cancer Res 82(18):3291\u20133306","journal-title":"Cancer Res"},{"key":"2987_CR102","doi-asserted-by":"publisher","first-page":"115","DOI":"10.12659\/MSM.895386","volume":"22","author":"J Wang","year":"2016","unstructured":"Wang J, Chen H, Chen X et al (2016) Expression of tumor-related macrophages and cytokines after surgery of triple-negative breast cancer patients and its implications. Med Sci Monit 22:115\u2013120","journal-title":"Med Sci Monit"},{"issue":"12","key":"2987_CR103","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1007\/s12094-021-02652-3","volume":"23","author":"H Kuroda","year":"2021","unstructured":"Kuroda H, Jamiyan T, Yamaguchi R et al (2021) Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes. Clin Transl Oncol 23(12):2513\u20132525","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"2987_CR104","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1115177","volume":"5","author":"M Hollm\u00e9n","year":"2016","unstructured":"Hollm\u00e9n M, Karaman S, Schwager S et al (2016) G-CSF regulates macrophage phenotype and associates with poor overall survival in human triple-negative breast cancer. Oncoimmunology 5(3):e1115177","journal-title":"Oncoimmunology"},{"issue":"2","key":"2987_CR105","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","volume":"40","author":"J Xue","year":"2014","unstructured":"Xue J, Schmidt SV, Sander J et al (2014) Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40(2):274\u2013288","journal-title":"Immunity"},{"issue":"6","key":"2987_CR106","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00428-020-02855-z","volume":"477","author":"T Jamiyan","year":"2020","unstructured":"Jamiyan T, Kuroda H, Yamaguchi R et al (2020) CD68- and CD163-positive tumor-associated macrophages in triple negative cancer of the breast. Virchows Arch Int J Pathol 477(6):767\u2013775","journal-title":"Virchows Arch Int J Pathol"},{"issue":"7","key":"2987_CR107","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1111\/cas.16200","volume":"115","author":"Y Dai","year":"2024","unstructured":"Dai Y, Ji Z, Liang H et al (2024) CD44v5 domain regulates crosstalk between TNBC cells and tumor\u2010associated macrophages by enhancing the IL\u20104R\/STAT3 axis. Cancer Sci 115(7):2235\u20132253","journal-title":"Cancer Sci"},{"issue":"8","key":"2987_CR108","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0273044","volume":"17","author":"KCS Pe","year":"2022","unstructured":"Pe KCS, Saetung R, Yodsurang V et al (2022) Triple-negative breast cancer influences a mixed M1\/M2 macrophage phenotype associated with tumor aggressiveness. PLoS One 17(8):e0273044","journal-title":"PLoS One"},{"key":"2987_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2022.106936","volume":"107","author":"Y Zou","year":"2022","unstructured":"Zou Y, Xie J, Zheng S et al (2022) Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery. Int J Surg 107:106936","journal-title":"Int J Surg"},{"issue":"10","key":"2987_CR110","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.7150\/jca.47566","volume":"12","author":"JH Ye","year":"2021","unstructured":"Ye JH, Wang XH, Shi JJ et al (2021) Tumor-associated macrophages are associated with response to neoadjuvant chemotherapy and poor outcomes in patients with triple-negative breast cancer. J Cancer 12(10):2886\u20132892","journal-title":"J Cancer"},{"key":"2987_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114126","volume":"180","author":"J Qiao","year":"2020","unstructured":"Qiao J, Chen Y, Mi Y et al (2020) Macrophages confer resistance to BET inhibition in triple-negative breast cancer by upregulating IKBKE. Biochem Pharmacol 180:114126","journal-title":"Biochem Pharmacol"},{"issue":"Pt B","key":"2987_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113207","volume":"142","author":"B Seok Han","year":"2024","unstructured":"Seok Han B, Ko S, Seok Park M et al (2024) Lidocaine combined with general anesthetics impedes metastasis of breast cancer cells via inhibition of TGF-\u03b2\/Smad-mediated EMT signaling by reprogramming tumor-associated macrophages. Int Immunopharmacol 142(Pt B):113207","journal-title":"Int Immunopharmacol"},{"key":"2987_CR113","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00309","volume":"10","author":"R Gong","year":"2020","unstructured":"Gong R, Jiang Y (2020) Non-coding RNAs in pancreatic ductal adenocarcinoma. Front Oncol 10:309","journal-title":"Front Oncol"},{"key":"2987_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.890768","volume":"9","author":"R Gulati","year":"2022","unstructured":"Gulati R, Nandi D, Sarkar K et al (2022) Exosomes as theranostic targets: implications for the clinical prognosis of aggressive cancers. Front Mol Biosci 9:890768","journal-title":"Front Mol Biosci"},{"key":"2987_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112406","volume":"136","author":"S Hadad","year":"2024","unstructured":"Hadad S, Khalaji A, Sarmadian AJ et al (2024) Tumor-associated macrophages derived exosomes; from pathogenesis to therapeutic opportunities. Int Immunopharmacol 136:112406","journal-title":"Int Immunopharmacol"},{"issue":"21","key":"2987_CR116","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1158\/1078-0432.CCR-20-0855","volume":"26","author":"KA Autio","year":"2020","unstructured":"Autio KA, Klebanoff CA, Schaer D et al (2020) Immunomodulatory activity of a colony-stimulating factor-1 receptor inhibitor in patients with advanced refractory breast or prostate cancer: a phase I study. Clin Cancer Res 26(21):5609\u20135620","journal-title":"Clin Cancer Res"},{"key":"2987_CR117","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-025-02070-1","volume":"27","author":"RA Leon-Ferre","year":"2025","unstructured":"Leon-Ferre RA, Dimitroff K, Yau C et al (2025) Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trial. Breast Cancer Res 27:115","journal-title":"Breast Cancer Res"},{"issue":"3","key":"2987_CR118","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10549-024-07555-9","volume":"209","author":"HS Rugo","year":"2025","unstructured":"Rugo HS, Campbell M, Yau C et al (2025) Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer. Breast Cancer Res Treat 209(3):487\u2013492","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"2987_CR119","doi-asserted-by":"publisher","first-page":"73","DOI":"10.36401\/JIPO-23-16","volume":"7","author":"J Ahmed","year":"2024","unstructured":"Ahmed J, Stephen B, Yang Y et al (2024) Phase Ib\/II study of lacnotuzumab in combination with spartalizumab in patients with advanced malignancies. Journal of Immunotherapy and Precision Oncology 7(2):73\u201381","journal-title":"Journal of Immunotherapy and Precision Oncology"},{"issue":"5","key":"2987_CR120","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13051086","volume":"13","author":"T Fujiwara","year":"2021","unstructured":"Fujiwara T, Healey J, Ogura K et al (2021) Role of tumor-associated macrophages in sarcomas. Cancers 13(5):1086","journal-title":"Cancers"},{"issue":"7","key":"2987_CR121","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41423-023-01013-0","volume":"20","author":"T Yoshimura","year":"2023","unstructured":"Yoshimura T, Li C, Wang Y et al (2023) The chemokine monocyte chemoattractant protein-1\/CCL2 is a promoter of breast cancer metastasis. Cell Mol Immunol 20(7):714\u2013738","journal-title":"Cell Mol Immunol"},{"issue":"9","key":"2987_CR122","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1021\/acs.molpharmaceut.7b00997","volume":"15","author":"S Shen","year":"2018","unstructured":"Shen S, Zhang Y, Chen KG et al (2018) Cationic polymeric nanoparticle delivering CCR2 siRNA to inflammatory monocytes for tumor microenvironment modification and cancer therapy. Mol Pharm 15(9):3642\u20133653","journal-title":"Mol Pharm"},{"issue":"11","key":"2987_CR123","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.7150\/ijbs.82317","volume":"19","author":"Y Yang","year":"2023","unstructured":"Yang Y, Li J, Lei W et al (2023) CXCL12-CXCR4\/CXCR7 axis in cancer: from mechanisms to clinical applications. Int J Biol Sci 19(11):3341\u20133359","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2987_CR124","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0022-1759(96)00056-7","volume":"193","author":"N van Rooijen","year":"1996","unstructured":"van Rooijen N, Sanders A, van den Berg TK (1996) Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine. J Immunol Methods 193(1):93\u201399","journal-title":"J Immunol Methods"},{"key":"2987_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-04525-7","volume":"6","author":"R Hirano","year":"2023","unstructured":"Hirano R, Okamoto K, Shinke M et al (2023) Tissue-resident macrophages are major tumor-associated macrophage resources, contributing to early TNBC development, recurrence, and metastases. Commun Biol 6:144","journal-title":"Commun Biol"},{"issue":"7","key":"2987_CR126","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S1470-2045(12)70226-7","volume":"13","author":"AHG Paterson","year":"2012","unstructured":"Paterson AHG, Anderson SJ, Lembersky BC et al (2012) Oral clodronate for adjuvant treatment of operable breast cancer (national surgical adjuvant breast and bowel project protocol b-34): a multicentre, placebo-controlled, randomised trial. Lancet Oncol 13(7):734\u2013742","journal-title":"Lancet Oncol"},{"issue":"15","key":"2987_CR127","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1200\/JCO.2002.11.080","volume":"20","author":"T Powles","year":"2002","unstructured":"Powles T, Paterson S, Kanis JA et al (2002) Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer. J Clin Oncol 20(15):3219\u20133224","journal-title":"J Clin Oncol"},{"issue":"9","key":"2987_CR128","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/00002018-200326090-00005","volume":"26","author":"S Atula","year":"2003","unstructured":"Atula S, Powles T, Paterson A et al (2003) Extended safety profile of oral clodronate after long-term use in primary breast cancer patients. Drug Saf 26(9):661\u2013671","journal-title":"Drug Saf"},{"issue":"48","key":"2987_CR129","doi-asserted-by":"publisher","first-page":"84248","DOI":"10.18632\/oncotarget.20539","volume":"8","author":"XJ Cai","year":"2017","unstructured":"Cai XJ, Wang Z, Cao JW et al (2017) Anti-angiogenic and anti-tumor effects of metronomic use of novel liposomal zoledronic acid depletes tumor-associated macrophages in triple negative breast cancer. Oncotarget 8(48):84248\u201384257","journal-title":"Oncotarget"},{"issue":"6","key":"2987_CR130","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/1758834011420599","volume":"3","author":"M Gnant","year":"2011","unstructured":"Gnant M (2011) Zoledronic acid in breast cancer: latest findings and interpretations. Ther Adv Med Oncol 3(6):293\u2013301","journal-title":"Ther Adv Med Oncol"},{"issue":"Suppl 1","key":"2987_CR131","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S1040-8428(11)70003-8","volume":"77","author":"JR Green","year":"2011","unstructured":"Green JR, Guenther A (2011) The backbone of progress\u2013preclinical studies and innovations with zoledronic acid. Crit Rev Oncol Hematol 77(Suppl 1):S3\u2013S12","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"2987_CR132","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ccr.2014.05.016","volume":"25","author":"CH Ries","year":"2014","unstructured":"Ries CH, Cannarile MA, Hoves S et al (2014) Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell 25(6):846\u2013859","journal-title":"Cancer Cell"},{"issue":"8","key":"2987_CR133","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1093\/annonc\/mdz163","volume":"30","author":"CA Gomez-Roca","year":"2019","unstructured":"Gomez-Roca CA, Italiano A, Le Tourneau C et al (2019) Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced\/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages. Ann Oncol Off J Eur Soc Med Oncol 30(8):1381\u20131392","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"18","key":"2987_CR134","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93397","volume":"2","author":"F Sato-Kaneko","year":"2017","unstructured":"Sato-Kaneko F, Yao S, Ahmadi A et al (2017) Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer. JCI Insight. 2(18):e93397","journal-title":"JCI Insight."},{"key":"2987_CR135","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.934084","volume":"13","author":"L Li","year":"2022","unstructured":"Li L, Chen X, Lv M et al (2022) Effect of platycodon grandiflorus polysaccharide on m1 polarization induced by autophagy degradation of socs1\/2 proteins in 3d4\/21 cells. Front Immunol 13:934084","journal-title":"Front Immunol"},{"issue":"1","key":"2987_CR136","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-03010-5","volume":"22","author":"A Palencia-Campos","year":"2024","unstructured":"Palencia-Campos A, Ruiz-Ca\u00f1as L, Abal-Sanisidro M et al (2024) Reprogramming tumor-associated macrophages with lipid nanosystems reduces PDAC tumor burden and liver metastasis. J Nanobiotechnology 22(1):795","journal-title":"J Nanobiotechnology"},{"key":"2987_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113593","volume":"381","author":"Y Wu","year":"2025","unstructured":"Wu Y, Park J, Xu E et al (2025) Microrna-induced reprogramming of tumor-associated macrophages for modulation of tumor immune microenvironment. J Control Release 381:113593","journal-title":"J Control Release"},{"issue":"2","key":"2987_CR138","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003564","volume":"10","author":"Y Du","year":"2022","unstructured":"Du Y, Liu Y, Wang D et al (2022) Peptidic microarchitecture-trapped tumor vaccine combined with immune checkpoint inhibitor or PI3K\u03b3 inhibitor can enhance immunogenicity and eradicate tumors. J Immunother Cancer 10(2):e003564","journal-title":"J Immunother Cancer"},{"issue":"7","key":"2987_CR139","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/annonc\/mdv163","volume":"26","author":"S Moulder","year":"2015","unstructured":"Moulder S, Helgason T, Janku F et al (2015) Inhibition of the phosphoinositide 3-kinase pathway for the treatment of patients with metastatic metaplastic breast cancer. Ann Oncol 26(7):1346\u20131352","journal-title":"Ann Oncol"},{"issue":"8","key":"2987_CR140","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1158\/1078-0432.CCR-21-3045","volume":"28","author":"F Batalini","year":"2022","unstructured":"Batalini F, Xiong N, Tayob N et al (2022) Phase 1b clinical trial with alpelisib plus olaparib for patients with advanced triple-negative breast cancer. Clin Cancer Res Off J Am Assoc Cancer Res 28(8):1493\u20131499","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"3","key":"2987_CR141","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031665","volume":"23","author":"P Ferrari","year":"2022","unstructured":"Ferrari P, Scatena C, Ghilli M et al (2022) Molecular mechanisms, biomarkers and emerging therapies for chemotherapy resistant TNBC. Int J Mol Sci 23(3):1665","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2987_CR142","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051540","volume":"15","author":"E Guill\u00e9n-Mancina","year":"2023","unstructured":"Guill\u00e9n-Mancina E, Jim\u00e9nez-Alonso JJ, Calder\u00f3n-Monta\u00f1o JM et al (2023) Artificial diets with selective restriction of amino acids and very low levels of lipids induce anticancer activity in mice with metastatic triple-negative breast cancer. Cancers 15(5):1540","journal-title":"Cancers"},{"issue":"4","key":"2987_CR143","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004218","volume":"10","author":"AS Rolig","year":"2022","unstructured":"Rolig AS, Rose DC, McGee GH et al (2022) Combining bempegaldesleukin (CD122-preferential IL-2 pathway agonist) and NKTR-262 (TLR7\/8 agonist) improves systemic antitumor CD8+ T cell cytotoxicity over BEMPEG+RT. J Immunother Cancer 10(4):e004218","journal-title":"J Immunother Cancer"},{"issue":"3","key":"2987_CR144","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI59643","volume":"122","author":"A Sica","year":"2012","unstructured":"Sica A, Mantovani A (2012) Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122(3):787\u2013795","journal-title":"J Clin Invest"},{"issue":"8","key":"2987_CR145","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","volume":"23","author":"A Christofides","year":"2022","unstructured":"Christofides A, Strauss L, Yeo A et al (2022) The complex role of tumor-infiltrating macrophages. Nat Immunol 23(8):1148\u20131156","journal-title":"Nat Immunol"},{"key":"2987_CR146","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1264774","volume":"14","author":"J Wang","year":"2023","unstructured":"Wang J, Zhu N, Su X et al (2023) Novel tumor-associated macrophage populations and subpopulations by single cell RNA sequencing. Front Immunol 14:1264774","journal-title":"Front Immunol"},{"issue":"1","key":"2987_CR147","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","volume":"10","author":"J Xu","year":"2025","unstructured":"Xu J, Ding L, Mei J et al (2025) Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments. Signal Transduct Target Ther 10(1):268","journal-title":"Signal Transduct Target Ther"},{"issue":"1\u20132","key":"2987_CR148","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/14728222.2025.2471581","volume":"29","author":"E Rismani","year":"2025","unstructured":"Rismani E, Hossein-Khannazer N, Hassan M et al (2025) Targeting glypican 3 by immunotoxins: the promise of immunotherapy in hepatocellular carcinoma. Expert Opin Ther Targets 29(1\u20132):59\u201373","journal-title":"Expert Opin Ther Targets"},{"key":"2987_CR149","doi-asserted-by":"publisher","first-page":"1683594","DOI":"10.3389\/fimmu.2025.1683594","volume":"16","author":"L Jiang","year":"2025","unstructured":"Jiang L, Dai Y, Li M et al (2025) The efficacy and safety of sacituzumab govitecan in the treatment of breast cancer: a systemic review and meta-analysis of emerging clinical data. Front Immunol 16:1683594","journal-title":"Front Immunol"},{"issue":"6","key":"2987_CR150","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0304985","volume":"19","author":"M Sue","year":"2024","unstructured":"Sue M, Tsubaki T, Ishimoto Y et al (2024) Blockade of SIRP\u03b1-CD47 axis by anti-SIRP\u03b1 antibody enhances anti-tumor activity of DXd antibody-drug conjugates. PLoS ONE 19(6):e0304985","journal-title":"PLoS ONE"},{"issue":"11","key":"2987_CR151","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1158\/0008-5472.CAN-24-2021","volume":"85","author":"Q Wei","year":"2025","unstructured":"Wei Q, Yang T, Zhang Z et al (2025) Perivascular niche-resident alveolar macrophages promote interstitial pneumonitis related to trastuzumab deruxtecan treatment. Cancer Res 85(11):2081\u20132099","journal-title":"Cancer Res"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-02987-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-026-02987-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-02987-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T18:02:14Z","timestamp":1782410534000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-026-02987-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":151,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2987"],"URL":"https:\/\/doi.org\/10.1007\/s10147-026-02987-3","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential conflicts of interest relevant to this review exist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Confict of interest"}}]}}